- Home
- BMY vs ELV Comparison
BMY vs ELV Comparison
Compare BMY & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- ELV
- Stock Information
- Founded
- BMY 1887
- ELV 1944
- Country
- BMY United States
- ELV United States
- Employees
- BMY N/A
- ELV N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- ELV Medical Specialities
- Sector
- BMY Health Care
- ELV Health Care
- Exchange
- BMY Nasdaq
- ELV Nasdaq
- Market Cap
- BMY 94.0B
- ELV 78.9B
- IPO Year
- BMY N/A
- ELV N/A
- Fundamental
- Price
- BMY $43.68
- ELV $329.80
- Analyst Decision
- BMY Hold
- ELV Buy
- Analyst Count
- BMY 14
- ELV 16
- Target Price
- BMY $57.54
- ELV $392.47
- AVG Volume (30 Days)
- BMY 15.5M
- ELV 1.9M
- Earning Date
- BMY 10-30-2025
- ELV 10-21-2025
- Dividend Yield
- BMY 5.82%
- ELV 2.03%
- EPS Growth
- BMY N/A
- ELV N/A
- EPS
- BMY 2.49
- ELV 24.39
- Revenue
- BMY $47,704,000,000.00
- ELV $194,820,000,000.00
- Revenue This Year
- BMY N/A
- ELV $12.63
- Revenue Next Year
- BMY N/A
- ELV $5.03
- P/E Ratio
- BMY $17.14
- ELV $13.79
- Revenue Growth
- BMY 2.57
- ELV 11.96
- 52 Week Low
- BMY $42.52
- ELV $273.71
- 52 Week High
- BMY $63.33
- ELV $458.75
- Technical
- Relative Strength Index (RSI)
- BMY 45.50
- ELV 40.65
- Support Level
- BMY $42.52
- ELV $335.10
- Resistance Level
- BMY $45.23
- ELV $347.26
- Average True Range (ATR)
- BMY 0.68
- ELV 8.26
- MACD
- BMY -0.00
- ELV -3.40
- Stochastic Oscillator
- BMY 42.88
- ELV 0.00
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About ELV Elevance Health Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.